Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Conditions
Cataract · Glaucoma · Ocular Hypertension
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Houston Eye Associates, Houston, Texas, United States
Contact: Study coordinator (Clinical Research Coordinator) · jmaguilar@houstoneye.com · 832-553-7100
Study leads
Paul Yoo, OD
Study Chair
SpyGlass Pharma